Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation

Metabolic dysfunction-associated fatty liver disease (MAFLD) is frequently linked to type 2 diabetes mellitus (T2DM), and both conditions exacerbate the progression of the other. However, there is currently no standardized treatment or drug for MAFLD. In this study, A MAFLD animal model through a hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mengmeng, Xia, Longqing, Song, Jia, Hu, Huiqing, Zang, Nan, Yang, Jingwen, Zou, Ying, Wang, Liming, Zheng, Xiaoyue, He, Qin, Liu, Jidong, Liu, Fuqiang, Liang, Kai, Sun, Lei, Chen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668385/
https://www.ncbi.nlm.nih.gov/pubmed/38001459
http://dx.doi.org/10.1186/s12944-023-01969-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668385/
https://www.ncbi.nlm.nih.gov/pubmed/38001459
http://dx.doi.org/10.1186/s12944-023-01969-y

Ejemplares similares